首页> 美国卫生研究院文献>Designed Monomers and Polymers >A new trinuclear cluster-based Cd(II) compound: photocatalytic property and nursing application values on the bacterial infection
【2h】

A new trinuclear cluster-based Cd(II) compound: photocatalytic property and nursing application values on the bacterial infection

机译:基于三核聚类的CD(II)化合物:光催化性质和细菌感染的护理申请价值

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A new Cd(II) coordination polymer with the formula of {[(CH3)2NH2][Cd3(NH2-bdc)3(btz)(H2O)]}n (1 NH2-H2bdc = 2-aminoterephthalic acid, Hbtz = 1 H-benzotriazole) was produced and then it was structurally characterized through powder X-ray diffraction (PXRD), the analysis of X-ray single-crystal diffraction, along with elemental analysis (EA). The photocatalytic property investigations indicate that compound 1 exhibits good activity for photodegradation of methyl violet (MV) with 60.7% of MV removal in 40 min under room temperature. Furthermore, the assessment of the compound’s treatment activity and nursing application values on the bacterial infection was conducted and its corresponding mechanism was also studied. Evaluation of the in vitro hemolysis of the compound was determined by measuring the degree of red blood cell lysis and hemoglobin release. The effect of new compounds on the relative proliferation rate of L-929 cells was measured by MTT assay. The ELISA detection kit showed that the compound could reduce the TNF-α and IL-1β content released into plasma. Next, the inhibitory activity of the compound on the bacterial survival gene expression was also proved with real-time RT-PCR. The hemolysis rate of the new compound to blood is 3.4%, which is less than the standard 5%, which is non-hemolytic reaction. The compound also has no obvious cytotoxicity and has good cell compatibility.
机译:具有{[(CH3)2NH2] [CD3(NH 2-BDC)3(BTZ)(H2O)3(BTZ)(H2O)]} N(1nH 2 -H2BDC = 2- amotopheThalic酸,HBTZ = 1的新的CD(II)配位聚合物。制备H-苯并三唑),然后通过粉末X射线衍射(PXRD)进行结构形式,X射线单晶衍射分析以及元素分析(EA)。光催化性质研究表明,化合物1在室温下在40分钟内具有60.7%的MV去除率的甲基紫(MV)的良好活性。此外,对化合物的治疗活性和护理施用值进行了对细菌感染的评估,还研究了其相应的机制。通过测量红细胞裂解和血红蛋白释放的程度来确定化合物的体外溶血的评价。通过MTT测定法测量新化合物对L-929细胞相对增殖速率的影响。 ELISA检测试剂盒表明该化合物可以将TNF-α和IL-1β含量降低到血浆中。接下来,还通过实时RT-PCR证实了化合物对细菌存活基因表达的抑制活性。新化合物对血液的溶血率为3.4%,小于标准的5%,这是非溶血反应。该化合物也没有明显的细胞毒性并且具有良好的细胞相容性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号